- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
27 Cards in this Set
- Front
- Back
|
What are clinical trials usually about?
|
answer specific medical question about therapeutic effect of a specific treatment
|
|
What does the protocol serve as in clinical trials?
|
- comprehensive document that guides treatment managment
|
|
How many phases are clinical trials divided into?
|
4 phases - each have unique purpose & general characteristics
|
|
What is the goal of a Phase 1 clinical trial?
|
- Determine maximum tolerated dose (MTD) of an investigational agent or combination of agents
- strict administration schedule |
|
What is the starting dose of the investigational agents used in Phase 1 studies?
|
dose for children is 80% of the MTD for adults
|
|
What patient demographics are common in Phase 1 trial recipients?
|
- Small trial
- 15-25 patients - refractory cancer not responsive to other treatment |
|
What other requirements must a patient meet in order to be entered into a Phase 1 trial?
|
- must have adequate organ function
- reasonable life expectancy - ability to function in life - all standard therapeutic options for curative treatment must have been exhausted |
|
What are some common reasons that families consent to Phase 1 clinical trials?
|
- possible cure
- disease response - control of symptoms - help others by contributing to research |
|
What are Phase II clinical trials designed to evaluate?
|
- efficacy of a new agent in treating specific type of cancer
|
|
Phase II clinical trials are disease specific and based on what?
|
1. biochemical data, pharm data, or both
2. preclinical screening in humor tumor cell lines 3. a suggestion of agent's antitumor activity in Phase 1 trials |
|
What are the patient requirements to be entered into a Phase II clinical trial?
|
- measurable disease
- normal major organ function - reasonable life expectancy - functional status |
|
What patients are the best patient's for Phase II trials?
|
those who have not already received intensive treatment
|
|
How is the sample size for Phase II clinical trials determined?
|
- based on # of patients needed to allow meaningful statistical conclusions to be drawn about treatment
|
|
What should the sample size protect against in Phase II trials?
|
- minimize chance that a potentially ineffective drug be accepted
- minimize chance that effective drug will be rejected |
|
When can Phase I and Phase II trials be combined into a pilot study?
|
when clinical trials are used to evaluate a treatment regimen rather than specific agent
|
|
What are Phase III trials used to assess?
|
- the role of a new treatment in terms of overall response, survival, QOL of newly diagnosed patients w/specific diagnosis
|
|
What is the goal of a Phase III trial?
|
- to determine whether the treatment is equivalent with or superio to current or standard treatment
|
|
What is a key element of Phase III trials?
|
- randomization between experimental group & control group (avoids bias)
- stratification by specific prognostic factors |
|
Why are Phase III trials usually implemented at a number of institutions or through cooperative groups?
|
They require a large number of patients
|
|
What are Phase IV clinical trials used for?
|
- further investigate the long-term safety & efficacy of a treatment
|
|
When are Phase IV trials usually implemented?
|
after the new treatment is approved for standard use
|
|
What is the goal of a Phase IV clinical trial?
|
- decrease side effects
- decrease toxicities - decrease late effects of treatment * all while continuing to provide acceptable cure rates |
|
Are Phase IV trials common in pediatric oncology patients?
|
No
|
|
What must followed in order to conduct clinical research trials?
|
Federal guidelines by US FDA
|
|
There are 4 FDA guidelines on page 75 - in brief summary they are...
|
1. Need IRB approval for human subjects
2. Informed consent must be obtained, & signed 3. Pt's med records should show eligibility requirements are met 4. Strict record keeping when investigational drugs are being used |
|
What 2 nursing assessments should be made when a patient is to begin a clinical trial?
|
1. ensure patient eligibility & consents are signed
2. ensure safe administration of drugs or therapies |
|
Nursing interventions for patients on clinical trials are the following...
|
1. Advocate for patient & family
2. Provide support 3. Provide education |